Ting Zhou

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Atopic Dermatitis

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fan Luo, Jiaxin Cao, Hongyun Zhao, Lusha Liu, Ting Yang, Xue Bai, Wenjuan Ma, Chaozhuo Lin, Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, Hongyun Zhao, Li Zhang
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for immunotherapy of cancer 12 (6) (2024)
Fan Luo, Jiaxin Cao, Hongyun Zhao, Lusha Liu, Ting Yang, Xue Bai, Wenjuan Ma, Chaozhuo Lin, Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, Hongyun Zhao, Li Zhang
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for immunotherapy of cancer 12 (6) (2024)
Fan Luo, Jiaxin Cao, Hongyun Zhao, Lusha Liu, Ting Yang, Xue Bai, Wenjuan Ma, Chaozhuo Lin, Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, Hongyun Zhao, Li Zhang
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for immunotherapy of cancer 12 (6) (2024)
Xiang Chen, Xueyuan Chen, Tingting Liu, Ting Zhou, Gang Chen, Huaqiang Zhou, Yan Huang, Wenfeng Fang, Yunpeng Yang, Ningning Zhou, Likun Chen, Silang Mo, Li Zhang, Yuanyuan Zhao
The maximum tumor growth rate predicts clinical outcomes of patients with small-cell lung cancer undergoing first-line chemotherapy plus immune-checkpoint inhibitor therapy. Cancer medicine (2023)
Bi Jing Xiao, Xiao Xian Sima, Gang Chen, Haimiti Gulizeba, Ting Zhou, Yan Huang
Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy. Cancer medicine (2023)
Ting Zhou, Yaxiong Zhang, Yuxiang Ma, Wenjuan Ma, Xuan Wu, Lu Huang, Weineng Feng, Huaqiang Zhou, Jiaqing Liu, Hongyun Zhao, Li Zhang, Yunpeng Yang, Yan Huang
Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial. Cancer 128 (22) (2022)